YewKhoon
2021-12-07
Like pls
EU antitrust regulator seeks input on Microsoft's $16 bln Nuance deal
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
5
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":606876135,"tweetId":"606876135","gmtCreate":1638865077738,"gmtModify":1638865078067,"author":{"id":3582789465327658,"idStr":"3582789465327658","authorId":3582789465327658,"authorIdStr":"3582789465327658","name":"YewKhoon","avatar":"https://static.tigerbbs.com/6242857b5af4d220ef956ac7f3f119a2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":27,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Like pls </p></body></html>","htmlText":"<html><head></head><body><p>Like pls </p></body></html>","text":"Like pls","highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/606876135","repostId":1100109020,"repostType":4,"repost":{"id":"1100109020","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638864730,"share":"https://www.laohu8.com/m/news/1100109020?lang=&edition=full","pubTime":"2021-12-07 16:12","market":"us","language":"en","title":"EU antitrust regulator seeks input on Microsoft's $16 bln Nuance deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1100109020","media":"Reuters","summary":"Dec 7 (Reuters) - EU's antitrust regulator is taking a deeper look into Microsoft Corp's $16 billion","content":"<p>Dec 7 (Reuters) - EU's antitrust regulator is taking a deeper look into Microsoft Corp's $16 billion deal for transcription technology company Nuance Communications Inc, asking customers and competitors to draw up a list of concerns, according to a questionnaire from last month seen by Reuters.</p>\n<p>The previously unreported outreach is the most extensive by an antitrust authority since the companies announced the acquisition in April, according to a person familiar with the matter.</p>\n<p>Microsoft declined to comment, and Nuance did not respond to a request for comment.</p>\n<p>After minimal review, the U.S. Department of Justice in June and the Australian Competition Commission in October said they would not contest the deal. The companies filed for approval from the European Commission's competition bureau last month, and the regulator has until Dec. 21 to clear the deal or open a bigger investigation.</p>\n<p>The companies had expected to close the deal by the end of this year, but said last month the timeline could slip to early next year.</p>\n<p>The questionnaire asks whether Microsoft and Nuance are competitors and whether a tie-up could affect clients and rivals, including whether Microsoft could favor Nuance over competing services.</p>\n<p>Nuance primarily sells transcription technology that is popular among doctors and call centers that want to automate note-talking. Analysts view the deal as bolstering Microsoft's presence in the healthcare market, and bringing it new voice and medical data to train artificial intelligence offerings in health, speech and biometric security.</p>\n<p>Like other big tech companies, Microsoft for years has grown its business through acquisitions, such as in advertising and video gaming. But in the last decade, Microsoft has avoided the target that recently has dogged its competitors Alphabet Inc's Google, Facebook Inc, Apple Inc and Amazon.com Inc, all of which are facing antitrust lawsuits and investigations on numerous issues.</p>\n<p>Steven Weber, a University of California Berkeley professor studying the intersection of technology and health care, said possible concerns about the pending deal could include Microsoft forcing its Office suite on Nuance customers by bundling them together.</p>\n<p>Nuance has said it serves 77% of U.S. hospitals.</p>\n<p>A key to its success has been has ensuring in deals with customers that it could use their data to advance its voice recognition systems, according to former chief executive Paul Ricci and another former employee.</p>\n<p>For instance, a Nuance contract with Augusta University Medical Center, obtained by Reuters this year through a public records request, reads, \"Customer shall provide Nuance access to voice and text data...and grants Nuance a perpetual, royalty-free license to copy, use and analyze such data for speech recognition research.\"</p>\n<p>Big cloud vendors such as Amazon and Microsoft typically do not have unfettered access to customers' data for research and development. But the opportunity to acquire those relationships and data explains Microsoft's interest in Nuance, the former employees said.</p>\n<p>Other providers of health transcription technologies include 3M Co and Philips.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU antitrust regulator seeks input on Microsoft's $16 bln Nuance deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU antitrust regulator seeks input on Microsoft's $16 bln Nuance deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-07 16:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 7 (Reuters) - EU's antitrust regulator is taking a deeper look into Microsoft Corp's $16 billion deal for transcription technology company Nuance Communications Inc, asking customers and competitors to draw up a list of concerns, according to a questionnaire from last month seen by Reuters.</p>\n<p>The previously unreported outreach is the most extensive by an antitrust authority since the companies announced the acquisition in April, according to a person familiar with the matter.</p>\n<p>Microsoft declined to comment, and Nuance did not respond to a request for comment.</p>\n<p>After minimal review, the U.S. Department of Justice in June and the Australian Competition Commission in October said they would not contest the deal. The companies filed for approval from the European Commission's competition bureau last month, and the regulator has until Dec. 21 to clear the deal or open a bigger investigation.</p>\n<p>The companies had expected to close the deal by the end of this year, but said last month the timeline could slip to early next year.</p>\n<p>The questionnaire asks whether Microsoft and Nuance are competitors and whether a tie-up could affect clients and rivals, including whether Microsoft could favor Nuance over competing services.</p>\n<p>Nuance primarily sells transcription technology that is popular among doctors and call centers that want to automate note-talking. Analysts view the deal as bolstering Microsoft's presence in the healthcare market, and bringing it new voice and medical data to train artificial intelligence offerings in health, speech and biometric security.</p>\n<p>Like other big tech companies, Microsoft for years has grown its business through acquisitions, such as in advertising and video gaming. But in the last decade, Microsoft has avoided the target that recently has dogged its competitors Alphabet Inc's Google, Facebook Inc, Apple Inc and Amazon.com Inc, all of which are facing antitrust lawsuits and investigations on numerous issues.</p>\n<p>Steven Weber, a University of California Berkeley professor studying the intersection of technology and health care, said possible concerns about the pending deal could include Microsoft forcing its Office suite on Nuance customers by bundling them together.</p>\n<p>Nuance has said it serves 77% of U.S. hospitals.</p>\n<p>A key to its success has been has ensuring in deals with customers that it could use their data to advance its voice recognition systems, according to former chief executive Paul Ricci and another former employee.</p>\n<p>For instance, a Nuance contract with Augusta University Medical Center, obtained by Reuters this year through a public records request, reads, \"Customer shall provide Nuance access to voice and text data...and grants Nuance a perpetual, royalty-free license to copy, use and analyze such data for speech recognition research.\"</p>\n<p>Big cloud vendors such as Amazon and Microsoft typically do not have unfettered access to customers' data for research and development. But the opportunity to acquire those relationships and data explains Microsoft's interest in Nuance, the former employees said.</p>\n<p>Other providers of health transcription technologies include 3M Co and Philips.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软","NUAN":"微妙通讯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100109020","content_text":"Dec 7 (Reuters) - EU's antitrust regulator is taking a deeper look into Microsoft Corp's $16 billion deal for transcription technology company Nuance Communications Inc, asking customers and competitors to draw up a list of concerns, according to a questionnaire from last month seen by Reuters.\nThe previously unreported outreach is the most extensive by an antitrust authority since the companies announced the acquisition in April, according to a person familiar with the matter.\nMicrosoft declined to comment, and Nuance did not respond to a request for comment.\nAfter minimal review, the U.S. Department of Justice in June and the Australian Competition Commission in October said they would not contest the deal. The companies filed for approval from the European Commission's competition bureau last month, and the regulator has until Dec. 21 to clear the deal or open a bigger investigation.\nThe companies had expected to close the deal by the end of this year, but said last month the timeline could slip to early next year.\nThe questionnaire asks whether Microsoft and Nuance are competitors and whether a tie-up could affect clients and rivals, including whether Microsoft could favor Nuance over competing services.\nNuance primarily sells transcription technology that is popular among doctors and call centers that want to automate note-talking. Analysts view the deal as bolstering Microsoft's presence in the healthcare market, and bringing it new voice and medical data to train artificial intelligence offerings in health, speech and biometric security.\nLike other big tech companies, Microsoft for years has grown its business through acquisitions, such as in advertising and video gaming. But in the last decade, Microsoft has avoided the target that recently has dogged its competitors Alphabet Inc's Google, Facebook Inc, Apple Inc and Amazon.com Inc, all of which are facing antitrust lawsuits and investigations on numerous issues.\nSteven Weber, a University of California Berkeley professor studying the intersection of technology and health care, said possible concerns about the pending deal could include Microsoft forcing its Office suite on Nuance customers by bundling them together.\nNuance has said it serves 77% of U.S. hospitals.\nA key to its success has been has ensuring in deals with customers that it could use their data to advance its voice recognition systems, according to former chief executive Paul Ricci and another former employee.\nFor instance, a Nuance contract with Augusta University Medical Center, obtained by Reuters this year through a public records request, reads, \"Customer shall provide Nuance access to voice and text data...and grants Nuance a perpetual, royalty-free license to copy, use and analyze such data for speech recognition research.\"\nBig cloud vendors such as Amazon and Microsoft typically do not have unfettered access to customers' data for research and development. But the opportunity to acquire those relationships and data explains Microsoft's interest in Nuance, the former employees said.\nOther providers of health transcription technologies include 3M Co and Philips.","news_type":1},"isVote":1,"tweetType":1,"viewCount":477,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":7,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/606876135"}
精彩评论